Racial-Ethnic Disparities in Stroke Care: The American ExperienceSalvador Cruz‐Flores, Amy L. Valderrama, Alejandro A. Rabinstein et al.|Stroke|2011Cited by 516
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trialMagdy Selim, Heena Olalde, Lydia D. Foster et al.|The Lancet Neurology|2019Cited by 249
2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke AssociationShyam Prabhakaran, Elisabeth B. Marsh, A Jadhav et al.|Stroke|2026Cited by 92
The Types of Neurological Deficits Might Not Justify Withholding Treatment in Patients With Low Total National Institutes of Health Stroke Scale ScoresEnrique C. Leira, Harold P. Adams|Stroke|2012Cited by 46
Methods for randomized, blinded, controlled evaluation of putative disease interventions in multi-laboratory, preclinical assessment networksKarisma Nagarkatti, Jessica Lamb, Márcio A. Diniz et al.|Research Square|2025Cited by 0